RxSight RXST
NASDAQ RXST
$5.32 -0.06 (-1.12%)
At close: Nov 13, 2026 · 4:00 PM EST

RxSight (RXST) Debt Ratio (2020 - 2023)

Updated

RxSight's Debt Ratio came in at 0.10 for Q2 2023, down 58.1% from 0.24 a year earlier and down 49.6% from the prior quarter.

Analysis

RxSight (RXST) Debt Ratio (2020 - 2023) Analysis & Trends

For FY2022, RxSight's Debt Ratio was 0.27, up 29.7% from FY2021.

  • Going back by year, Debt Ratio was 0.21 in FY2021 (-14.9%) and 0.24 in FY2020.
  • The Q2 2023 figure represents the lowest quarterly Debt Ratio in data going back to Q4 2020.
  • Year-over-year, Debt Ratio increased in two of the last six quarters, with an average decline of 10.9%.
  • Business Quant data shows RXST's Debt Ratio at 0.20 (Q1 2023), 0.27 (Q4 2022) and 0.26 (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 0.36
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 0.29
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 0.28
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn -
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 0.30
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 0.32
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 0.26
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 0.04
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 0.31
10 RxSight 223.05 Mn -31.65 Mn 18.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 0.10
Mar 31, 2023 0.20
Dec 31, 2022 0.27
Sep 30, 2022 0.26
Jun 30, 2022 0.24
Mar 31, 2022 0.23
Dec 31, 2021 0.21
Sep 30, 2021 0.19
Jun 30, 2021 0.42
Dec 31, 2020 0.24
API Access

RxSight Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RXST&period=max&api_key=YOUR_API_KEY